Charles Wells, HEAD of Therapeutics Development, Gates Medical Research Institute

Annual compensation details

$603,544

＋5.5%

HEAD of Therapeutics Development

2024

$524k org

40 hrs/wk

$81k other

--

$572,220

＋2.7%

HEAD of Therapeutics Development

2023

$497k org

40 hrs/wk

$77k other

--

Total compensation by year

2024

Other employees at Gates Medical Research Institute

Trevor Mundel

Board Chair and Director

$1,466,448

$0 from org$1,396,369 from related$70,079 other

Carolyn Ainslie

Director

$1,109,332

$0 from org$1,025,020 from related$84,312 other

Michael Dunne

Chief Medical Officer (END 12/24)

$910,041

$812,206 from orgNo related comp$97,835 other

Harish Kaushal

Treasurer

$806,923

$712,706 from orgNo related comp$94,217 other

Debra Weiss

Chief Operating Officer

$773,052

$690,828 from orgNo related comp$82,224 other

Toni Hoover

Director

$724,790

$0 from org$642,426 from related$82,364 other

Jared Silverman

HEAD of Translational Discovery

$669,605

$573,001 from orgNo related comp$96,604 other

Patrice Matchaba

Chief Executive Officer (Start 6/24)

$652,494

$584,380 from orgNo related comp$68,114 other

Piper Trelstad

HEAD of CHEM, Manufac, and Controls

$642,743

$548,565 from orgNo related comp$94,178 other

Charles Wells

Annual compensation details

Total compensation by year

Compare the compensation of Charles Wells to:

Other employees at Gates Medical Research Institute

Other people named Charles Wells

Revisions to this profile

Get an email update when compensation for Charles Wells is updated

Related Jobs

Other people named Charles Wells